Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 57 (3), 299-304

Effect of the Lipidic Lipidosterolic Extract of Serenoa Repens (Permixon) on the Ionophore A23187-stimulated Production of Leukotriene B4 (LTB4) From Human Polymorphonuclear Neutrophils

Affiliations

Effect of the Lipidic Lipidosterolic Extract of Serenoa Repens (Permixon) on the Ionophore A23187-stimulated Production of Leukotriene B4 (LTB4) From Human Polymorphonuclear Neutrophils

M Paubert-Braquet et al. Prostaglandins Leukot Essent Fatty Acids.

Abstract

Although the lipidic extract of Serenoa repens (LESSr, Permixon, Sereprostat) is widely used in patients suffering from benign prostatic hypertrophy (BPH), its mechanism of action is not fully elucidated. It has been demonstrated that infiltration of the prostate by inflammatory cells is one of the aetiologic factors involved in the development of BPH. These inflammatory cell types, such as polymorphonuclear neutrophils (PMNs), produce chemotactic mediators and contribute to the development of the disease. Among the chemotactic factors generated by inflammatory cell types, the derivatives of arachidonic acid have been extensively studied. For instance, leukotriene (LT) B4 is one of the most potent chemotactic factors for PMNs and also exhibits a wide range of biological activities. In order to investigate the potential action of LESSr on arachidonate metabolism, and particularly on the synthesis of LTB4, the effect of this extract on the in vitro synthesis of LT by human PMNs stimulated with the calcium ionophore A23187 was investigated. LESSr significantly inhibits the production of 5-lipoxygenase metabolites (5-HETE, 20-COOH LTB4, LTB4 and 20-OH LTB4) at concentrations as low as 5 microg/ml. Such an effect of LESSr was also observed in the presence of exogenous arachidonic acid (20 microg/ml) and when f-MLP was used as the agonist, suggesting that inhibition of LTB4 production by the extract was unrelated to phospholipase A2 blockade and independent of the stimulating agent. The capability of LESSr to antagonize 5-lipoxygenase metabolites production may contribute, at least partly, to the understanding of its therapeutic activity on the inflammatory component of BPH.

Similar articles

See all similar articles

Cited by 15 articles

See all "Cited by" articles

LinkOut - more resources

Feedback